In our set of samples, Tumor #1 and Tumor #3 carried mutations in PIK3CA, with variant allele frequencies of 38% and 26%, and Tumor #4 harbored an NF1 mutation, which might activate the PI3K signaling pathway. The gene discussed is PIK3CA; the disease is neoplasm.